taking glp 1 while breastfeeding GLP-1 meds like Ozempic® and Wegovy® are everywhere — but what if you're breastfeeding? 🤱 Early studies show minimal transfer into breast milk, yet we don't have enough data to call them GLP-1 and breastfeeding – what

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE )a multicentre, double-blind, randomised, placebo-controlled trial

GLP-1 Weight Loss and Loose Skin: Understanding Facial Fat Loss and Collagen Changes Date Written by Rana Bassal Revised by Martha Viera, MD GLP-1 weight loss may reveal facial changes as fat pads shrink and collagen and elastin naturally decline with age

The older adults are at higher risk of developing type 2 diabetes

In 2024 semaglutide (Wegovy) became the first weight loss drug to also be approved for the reduction of risk of serious cardiovascular events in patients with cardiovascular disease and obesity or overweight

A significant limitation of the current clinical evidence is its reliance on post-hoc analyses of cardiovascular outcome trials and large-scale retrospective studies